Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Fernando Calais Da Silva; Philip H. Powell; Stephen Prescott; Ziya Kirkali; Cees van de Beek; Thierry Gorlia; Theo M. de Reijke

doi:10.1016/j.eururo.2009.12.024

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard J. Sylvester^*, Maurizio A. Brausi, Wim J. Kirkels, Wolfgang Hoeltl, Fernando Calais Da Silva, Philip H. Powell, Stephen Prescott, Ziya Kirkali, Cees van de Beek, Thierry Gorlia, Theo M. de Reijke

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

231 Citations (Web of Science)

Original language	English
Pages (from-to)	766-773
Journal	European Urology
Volume	57
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2009.12.024
Publication status	Published - May 2010

Keywords

Bacillus Calmette-Guerin
Epirubicin
Instillation therapy
Isoniazid
Non-muscle-invasive bladder cancer
Randomized clinical trial
Urothelial carcinoma of the bladder

Access to Document

10.1016/j.eururo.2009.12.024

Cite this

Sylvester, R. J., Brausi, M. A., Kirkels, W. J., Hoeltl, W., Da Silva, F. C., Powell, P. H., Prescott, S., Kirkali, Z., van de Beek, C., Gorlia, T., & de Reijke, T. M. (2010). Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. European Urology, 57(5), 766-773. https://doi.org/10.1016/j.eururo.2009.12.024

Sylvester, Richard J. ; Brausi, Maurizio A. ; Kirkels, Wim J. ; Hoeltl, Wolfgang ; Da Silva, Fernando Calais ; Powell, Philip H. ; Prescott, Stephen ; Kirkali, Ziya ; van de Beek, Cees ; Gorlia, Thierry ; de Reijke, Theo M. / Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. In: European Urology. 2010 ; Vol. 57, No. 5. pp. 766-773.

@article{0b40a4232eb549fdbdbeb3e62777b38e,

title = "Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder",

keywords = "Bacillus Calmette-Guerin, Epirubicin, Instillation therapy, Isoniazid, Non-muscle-invasive bladder cancer, Randomized clinical trial, Urothelial carcinoma of the bladder",

author = "Sylvester, {Richard J.} and Brausi, {Maurizio A.} and Kirkels, {Wim J.} and Wolfgang Hoeltl and {Da Silva}, {Fernando Calais} and Powell, {Philip H.} and Stephen Prescott and Ziya Kirkali and {van de Beek}, Cees and Thierry Gorlia and {de Reijke}, {Theo M.}",

year = "2010",

month = may,

doi = "10.1016/j.eururo.2009.12.024",

language = "English",

volume = "57",

pages = "766--773",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

Sylvester, RJ, Brausi, MA, Kirkels, WJ, Hoeltl, W, Da Silva, FC, Powell, PH, Prescott, S, Kirkali, Z, van de Beek, C, Gorlia, T & de Reijke, TM 2010, 'Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder', European Urology, vol. 57, no. 5, pp. 766-773. https://doi.org/10.1016/j.eururo.2009.12.024

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. / Sylvester, Richard J.; Brausi, Maurizio A.; Kirkels, Wim J.; Hoeltl, Wolfgang; Da Silva, Fernando Calais; Powell, Philip H.; Prescott, Stephen; Kirkali, Ziya; van de Beek, Cees; Gorlia, Thierry; de Reijke, Theo M.

In: European Urology, Vol. 57, No. 5, 05.2010, p. 766-773.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

AU - Sylvester, Richard J.

AU - Brausi, Maurizio A.

AU - Kirkels, Wim J.

AU - Hoeltl, Wolfgang

AU - Da Silva, Fernando Calais

AU - Powell, Philip H.

AU - Prescott, Stephen

AU - Kirkali, Ziya

AU - van de Beek, Cees

AU - Gorlia, Thierry

AU - de Reijke, Theo M.

PY - 2010/5

Y1 - 2010/5

KW - Bacillus Calmette-Guerin

KW - Epirubicin

KW - Instillation therapy

KW - Isoniazid

KW - Non-muscle-invasive bladder cancer

KW - Randomized clinical trial

KW - Urothelial carcinoma of the bladder

U2 - 10.1016/j.eururo.2009.12.024

DO - 10.1016/j.eururo.2009.12.024

M3 - Article

C2 - 20034729

VL - 57

SP - 766

EP - 773

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -

Sylvester RJ, Brausi MA, Kirkels WJ, Hoeltl W, Da Silva FC, Powell PH et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. European Urology. 2010 May;57(5):766-773. https://doi.org/10.1016/j.eururo.2009.12.024